ArticleCureus2025
Rapid Progression of Molar Pregnancy to Choriocarcinoma With Pulmonary Metastases.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postmolar choriocarcinoma is a rare, highly malignant tumor of the placenta with characteristic histologic and clinical features. We present a case of a 31-year-old G3P2 female patient with evidence of a complete molar pregnancy indicated by symptoms of severe nausea and vomiting, a heterogenous, cystic mass on ultrasound, and human chorionic gonadotropin (hCG) levels above 900,000 IU/mL. Two days after the evacuation of the molar pregnancy, she developed symptomatic pulmonary metastases with markedly increased hCG levels and worsening symptoms. She was treated for pulmonary emboli and shortly started on EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy. However, due to persistently elevated hCG levels and rapid disease progression, she was ultimately referred to a tertiary trophoblastic disease center. She completed her chemotherapy regimen with subsequent return of her hCG levels to normal values and underwent a hysterectomy with complete removal of the tumor. While choriocarcinoma has an excellent prognosis, the accelerated progression and extreme hCG levels of this case highlight the need for further investigations into the management of molar pregnancy patients with high-risk features for gestational trophoblastic neoplasia (GTN), as well as the pathomechanism of this disease trajectory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.